After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
An investor should make good money on any turn in the drug maker's business or in investor sentiment.
The stock has broken free of tiresome resistance in a big way.
Teva Pharmaceuticals (TEVA) stock is rising in early morning trading today after the company won antitrust approval to purchase Allergan's (AGN) generics business.
Cramer agrees with analysts' bullish calls on Gap and Allergan.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.